These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29754194)

  • 1. Loss of P2X7 receptor function dampens whole body energy expenditure and fatty acid oxidation.
    Giacovazzo G; Apolloni S; Coccurello R
    Purinergic Signal; 2018 Sep; 14(3):299-305. PubMed ID: 29754194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance.
    Coccurello R; Volonté C
    Front Endocrinol (Lausanne); 2020; 11():199. PubMed ID: 32528404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of P2X7 nucleotide receptor function leads to abnormal fat distribution in mice.
    Beaucage KL; Xiao A; Pollmann SI; Grol MW; Beach RJ; Holdsworth DW; Sims SM; Darling MR; Dixon SJ
    Purinergic Signal; 2014; 10(2):291-304. PubMed ID: 24222214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P2X7 ion channel is dispensable for energy and metabolic homeostasis of white and brown adipose tissues.
    Tian T; Heine M; Evangelakos I; Jaeckstein MY; Schaltenberg N; Stähler T; Koch-Nolte F; Kumari M; Heeren J
    Purinergic Signal; 2020 Dec; 16(4):529-542. PubMed ID: 33025427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors.
    Vijayakumar RS; Lin Y; Shia KS; Yeh YN; Hsieh WP; Hsiao WC; Chang CP; Chao YS; Hung MS
    Int J Obes (Lond); 2012 Jul; 36(7):999-1006. PubMed ID: 21894162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
    Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
    Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity Resistance and Enhanced Insulin Sensitivity in Ahnak-/- Mice Fed a High Fat Diet Are Related to Impaired Adipogenesis and Increased Energy Expenditure.
    Shin JH; Kim IY; Kim YN; Shin SM; Roh KJ; Lee SH; Sohn M; Cho SY; Lee SH; Ko CY; Kim HS; Choi CS; Bae YS; Seong JK
    PLoS One; 2015; 10(10):e0139720. PubMed ID: 26466345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global IP6K1 deletion enhances temperature modulated energy expenditure which reduces carbohydrate and fat induced weight gain.
    Zhu Q; Ghoshal S; Tyagi R; Chakraborty A
    Mol Metab; 2017 Jan; 6(1):73-85. PubMed ID: 28123939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic physiology and skeletal muscle phenotypes in male and female myoglobin knockout mice.
    Ono-Moore KD; Olfert IM; Rutkowsky JM; Chintapalli SV; Willis BJ; Blackburn ML; Williams DK; O'Reilly J; Tolentino T; Lloyd KCK; Adams SH
    Am J Physiol Endocrinol Metab; 2021 Jul; 321(1):E63-E79. PubMed ID: 33969704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion.
    Zhang L; Macia L; Turner N; Enriquez RF; Riepler SJ; Nguyen AD; Lin S; Lee NJ; Shi YC; Yulyaningsih E; Slack K; Baldock PA; Herzog H; Sainsbury A
    Int J Obes (Lond); 2010 Feb; 34(2):357-73. PubMed ID: 19918245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Sam68 triggers adipose tissue browning.
    Zhou J; Cheng M; Boriboun C; Ardehali MM; Jiang C; Liu Q; Han S; Goukassian DA; Tang YL; Zhao TC; Zhao M; Cai L; Richard S; Kishore R; Qin G
    J Endocrinol; 2015 Jun; 225(3):181-9. PubMed ID: 25934704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure.
    Somm E; Henrichot E; Pernin A; Juge-Aubry CE; Muzzin P; Dayer JM; Nicklin MJ; Meier CA
    Diabetes; 2005 Dec; 54(12):3503-9. PubMed ID: 16306368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.
    Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Rector RS; Thyfault JP
    Exp Physiol; 2018 Mar; 103(3):408-418. PubMed ID: 29215172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR30 regulates diet-induced adiposity in female mice and adipogenesis in vitro.
    Wang A; Luo J; Moore W; Alkhalidy H; Wu L; Zhang J; Zhen W; Wang Y; Clegg DJ; Bin Xu ; Cheng Z; McMillan RP; Hulver MW; Liu D
    Sci Rep; 2016 Oct; 6():34302. PubMed ID: 27698362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of P2X7 Enhances Whole Body Energy Metabolism in Mice.
    Giacovazzo G; Fabbrizio P; Apolloni S; Coccurello R; Volonté C
    Front Cell Neurosci; 2019; 13():390. PubMed ID: 31496939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors.
    Sutton GM; Trevaskis JL; Hulver MW; McMillan RP; Markward NJ; Babin MJ; Meyer EA; Butler AA
    Endocrinology; 2006 May; 147(5):2183-96. PubMed ID: 16469808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of diet-induced obesity by a combination of tea-catechin intake and regular swimming.
    Murase T; Haramizu S; Shimotoyodome A; Tokimitsu I
    Int J Obes (Lond); 2006 Mar; 30(3):561-8. PubMed ID: 16247510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tbc1d1 deletion suppresses obesity in leptin-deficient mice.
    Dokas J; Chadt A; Joost HG; Al-Hasani H
    Int J Obes (Lond); 2016 Aug; 40(8):1242-9. PubMed ID: 27089993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
    Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
    Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different contribution of muscle and liver lipid metabolism to endurance capacity and obesity susceptibility of mice.
    Haramizu S; Nagasawa A; Ota N; Hase T; Tokimitsu I; Murase T
    J Appl Physiol (1985); 2009 Mar; 106(3):871-9. PubMed ID: 19131482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.